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Abstract 
Even though intracardiac sarcoma metastases are rare, they have been previously 
reported in the literature. We report the case of a 60-year-old man who had a synovial 
sarcoma with metastasis in the right ventricle. These findings were associated with the 
presence of a new cardiac murmur and severe thrombocytopenia. The treatment with 
systemic chemotherapy resulted in a normalization of the patient’s hematologic profile 
and in a reduction of the intracardiac mass. The patient subsequently underwent 
intracardiac tumor resection. 
 
Case Report 
A 60-year-old man was admitted to our institution with dyspnea, fatigue and diminishing exercise 
tolerance, which had begun a week before admission. He also complained of morning facial edema and 
anorexia. 
Twelve months earlier, a biphasic synovial sarcoma of the spermatic cord had been excised. 
Metastatic evaluation was negative. Nine months after the first surgery, the patient underwent a left 
inguinal orchiectomy due to a local relapse. Microscopically, a biphasic synovial sarcoma with a 
maximal diameter of 1.5 cm, vascular invasion and 2-mm deep margins was identified. Testicles and 
spermatic cord did not present neoplastic tissue. 
At admission, physical examination revealed a new murmur and facial edema. The ECG 
demonstrated normal sinus rhythm. Laboratory investigation was remarkable for the following 
(reference ranges in parentheses): WBC 14.86 × 10
9/l (7.0–10.0 × 10
9/l); platelets 24 × 10
9/l (150–300 × 
10
9/l); AST 69 U/l (<37 U/l); ALT 203 U/l (<41 U/l), and GGT 361 U/l (12–73 U/l). The physical 
examination showed no splenomegaly or petechiae. An echo-Doppler evaluation of the inferior limbs 
excluded deep venous thrombosis, but raised the suspicion of tricuspid insufficiency. The 
ventilation/perfusion scan indicated a low probability of pulmonary thromboembolism. A CT scan of 
the thorax revealed an asymmetry in the volume of the right cavities, particularly of the atrium and the 
right ventricular cavities, and poor filling of the right ventricle that seemed to be due to an 
intracavitary/intraventricular right mass. This mass filled the lumen in practically its whole diameter, 
protruding into the right atrium and progressing to the pulmonary artery until its bifurcation (fig. 1). 
There was no safe evidence of a thromboembolic phenomenon in the remaining pulmonary vasculature. 
In the lung parenchyma, no evidence of recent or old lesions could be found.  
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The transesophageal echocardiogram performed to investigate the new murmur showed a 
heterogeneous intracardiac mass filling the whole right ventricle and extending to the right atrium 
(fig. 2). As a result, following events could be observed: a certain degree of compression of the left 
ventricle; dilatation of the right cavities; mild tricuspid regurgitation; preservation of the left ventricular 
ejection function (66%), and dilatation of the inferior vena cava. 
A right endomyocardic transjugular percutaneous biopsy was performed. The pathological 
evaluation showed cardiac metastasis of the synovial sarcoma of the spermatic cord. The myelogram 
revealed that the three hematopoietic series were conserved and free from neoplastic invasion. A CT of 
the abdomen and a PET scan showed no evidence of additional outbreaks of disease. 
The patient subsequently received one cycle of chemotherapy with adriamycin (75 mg/m
2). A repeat 
transesophageal echocardiogram performed on day 15 of treatment showed a mass reduction (fig. 2). 
The patient received a total of five chemotherapy courses with adriamycin, administered in 21-day 
cycles. There was a partial response higher than 70%, documented by the CT scan and MRI of the 
thorax (fig. 3), the echocardiogram and by laboratory tests (normal platelet count), and a favorable 
evolution of the clinical situation was shown. 
Unfortunately, after five months of relapse-free disease, there were signs of disease progression, with 
hemodynamic repercussions, and the patient subsequently underwent partial intracardiac tumor 
resection, with palliative intention. After surgery, there was a quick progression of the disease, thus no 
additional second-line chemotherapy was administered. 
Discussion 
Primary cardiac tumors are observed in 0.0017–0.03% of unselected patients at 
postmortem evaluation [1, 2]. In the study by Murphy et al [3], 77% of the tumors were 
primary benign, 14% were metastatic and 9% were primary malignant. Myxoma was the 
most common benign tumor and sarcoma was the most common primary malignant 
tumor. The most common primary sites of cardiac metastasis were, in order of decreasing 
frequency, the lung and pleura, lymphoma, breast and esophagus [4]. Although 10–25% 
of patients with terminal cancer have cardiac metastasis [5, 6], clinical evidence is scarce, 
and premortem diagnosis is unpredictable. 
Intracardiac metastases of sarcomas are rare. Additionally, sarcoma metastasis with 
valvular involvement, which was the case in our patient, is even more rare. Harting et al. 
[7] reported a case of sarcoma with metastasis in the right ventricle. The primary tumor 
was in the left axilla and had been excised 27 months before with aggressive surgical 
intervention. 
Characteristic symptoms of intracardiac tumors include: dyspnea, chest pain, cough, 
hemoptysis, syncope and right ventricular failure [7, 8]. Echocardiography is the 
procedure of choice for detecting intracardiac tumors, including the more common 
metastatic [9, 10] as well as primary tumors [9, 11]. 
Thrombocytopenia associated with a large metastatic intracardiac and intracaval mass 
arising from a sarcoma of the spermatic cord is not common. Fishman et al. [8] reported a 
case of thrombocytopenia associated with hemolytic anemia in a patient with intracardiac 
metastasis originating from a testicular teratoma. There was a rapid and sustained 
normalization of his hematologic profile following mass resection. Vohra et al. [12] also 
described a patient with an intracardiac teratoma associated with thrombocytopenia and 
severe hemolytic anemia. This was thought to be due to intravascular consumption which 
responded only transiently to systemic chemotherapy.  
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Our patient’s platelet count normalized with the start of systemic chemotherapy, which 
was sustained. Because the clinical situation was extremely serious and there was 
hemodynamic instability, the oncology team decided to suppress ifosfamide from the 
chemotherapy regimen. We believe that the ventricular mass adherent to the tricuspid 
valve created an environment of turbulent flow that was responsible for the destruction of 
the platelets. This is supported by the refractoriness to corticosteroid therapy and by the 
improvement of the platelet count with the reduction of the size of the mass. 
Although surgical treatment of benign cardiac tumors is often curative, malignant 
tumors, especially metastatic tumors, present a difficult clinical challenge [7]. Complete 
surgical resection is indicated for patients with a preoperative Karnofsky performance 
status of >80%, minimal extracardiac disease or a deteriorating clinical condition related 
to cardiac symptoms [7, 13]. The operative risk and the extent of disease spread must be 
carefully considered and, as such, surgical treatment was not considered the best initial 
option in our patient. 
A diagnosis of cardiac neoplasm, especially metastatic disease, carries a poor prognosis. 
Kamiya et al. [14] published a review of 135 patients with malignant cardiac tumors. Only 
three patients remained alive three years after the surgery. Most of them died within 12 
months after the surgery. In secondary tumors, operative intervention is less often carried 
out than in primary cardiac neoplasms. The perioperative mortality rate of secondary 
tumors is around 40%. 
Conclusion 
Intracardiac metastasis arising from sarcomas seldom occurs. The presence of a new 
cardiac murmur should alert the physician to the possibility of intracardiac spread. This 
event can cause severe secondary thrombocytopenia, which is not responsive to empiric 
therapy with corticosteroids. In oligometastatic sarcomas, and when surgical resection is 
not possible, chemotherapy is an effective therapeutic approach, capable of providing a 
hematologic response as well as a reduction in the size of the neoplasm, with subsequent 
correction of the hemodynamic imbalance. In our patient, surgery was finally possible 
after the chemotherapy regimen, but did not have a significant impact on the disease 
evolution. Due to the therapeutic measures imposed, the patient had a survival time 
higher than one year with a good symptomatic control. 
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Fig. 1. CT of the thorax before chemotherapy regimen, demonstrating a intracavitary/intraventricular 
right mass. This mass filled the lumen in practically its whole diameter, protruding into the right 
atrium and progressing to the pulmonary artery until its bifurcation. 
 
 
 
Fig. 2. Transesophageal echocardiogram. (1) Before chemotherapy regimen; a heterogeneous 
intracardiac mass filling the whole right ventricle and extending to the right atrium can be seen. 
(2) After chemotherapy regimen; a mass reduction is evident. 
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Fig. 3. MRI of the thorax after chemotherapy regimen, demonstrating a significant mass reduction. 
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